The vaccine expert talks about what this could mean for the fall, whether more safety studies are really needed and what ...

In a significant policy shift, the FDA has decided to halt the blanket recommendation for annual boosters for healthy individuals under 65, specifically urging a more cautious approach. FDA ...

A highly anticipated White House report blames a crisis of chronic illness on ultraprocessed foods, chemical exposures, ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

The White House has released its long-awaited “MAHA Report” outlining the government’s target areas for addressing childhood ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.